• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Putting biomarkers into practice

March 8, 2023  

CNS effects of Wegovy (semaglutide)

February 28, 2023  

Putting shared decision-making into practice

February 16, 2023  

CLINICAL CASES IN MS – AN OLDER PATIENT WITH STABLE DISEASE

February 9, 2023  

The end of MS phenotypes?

January 26, 2023  

MS Awards 2022 – Oddities and Observations

December 9, 2022  

Effectiveness of COVID boosters in MS: an update

November 30, 2022  

2022 – the year in review

November 29, 2022  

CLINICAL CASES IN MS – A STABLE PATIENT WITH RISING JCV INDEX

November 17, 2022  

SPMS pathogenesis and treatment

November 14, 2022  
Previous
10
11
12
13
14
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Anti-CD20 therapy in MS: comparing efficacy and safety posted on July 21, 2026
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Highlights of EAN 2026 – Part 1 posted on June 30, 2026
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions